CIMEIO Trademark

Trademark Overview


On Tuesday, April 27, 2021, a trademark application was filed for CIMEIO with the United States Patent and Trademark Office. The USPTO has given the CIMEIO trademark a serial number of 79315651. The federal status of this trademark filing is REGISTERED as of Tuesday, December 6, 2022. This trademark is owned by CIMEIO THERAPEUTICS AG. The CIMEIO trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical products for gene and cell therapy not for use in connection with dental products or services

Gene, T cell, B cell and stem cell therapy services; consultant services in the fields of gene, T cell, B cell and stem cell therapy, none of the foregoing for use in connection with dental-related products and services

Pharmaceutical research and development services in the fields of gene therapy and cell therapy; medical and pharmaceutical research and development services, all in the fields of gene therapy and cell therapy; research services relating to pharmaceutical products for gene and cell therapy; biochemistry research services relating to cell therapy and gene therapy, none of the foregoing for use in connection with dental-related products and services
cimeio

General Information


Serial Number79315651
Word MarkCIMEIO
Filing DateTuesday, April 27, 2021
Status700 - REGISTERED
Status DateTuesday, December 6, 2022
Registration Number6914827
Registration DateTuesday, December 6, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2022

Trademark Statements


Goods and ServicesPharmaceutical products for gene and cell therapy not for use in connection with dental products or services
Translation of Words in MarkThe wording CIMEIO has no meaning in a foreign language.
Goods and ServicesGene, T cell, B cell and stem cell therapy services; consultant services in the fields of gene, T cell, B cell and stem cell therapy, none of the foregoing for use in connection with dental-related products and services
Goods and ServicesPharmaceutical research and development services in the fields of gene therapy and cell therapy; medical and pharmaceutical research and development services, all in the fields of gene therapy and cell therapy; research services relating to pharmaceutical products for gene and cell therapy; biochemistry research services relating to cell therapy and gene therapy, none of the foregoing for use in connection with dental-related products and services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 19, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 19, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 19, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCIMEIO THERAPEUTICS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameCIMEIO THERAPEUTICS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameCIMEIO THERAPEUTICS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Wednesday, April 19, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, March 23, 2023FINAL DISPOSITION NOTICE SENT TO IB
Thursday, March 23, 2023FINAL DISPOSITION PROCESSED
Monday, March 6, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 6, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 6, 2022REGISTERED-PRINCIPAL REGISTER
Monday, October 10, 2022NOTIFICATION PROCESSED BY IB
Tuesday, September 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 20, 2022PUBLISHED FOR OPPOSITION
Wednesday, September 7, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 7, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 31, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 19, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 18, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 14, 2022REFUSAL PROCESSED BY IB
Tuesday, January 25, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, January 25, 2022REFUSAL PROCESSED BY MPU
Tuesday, January 4, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, January 3, 2022NON-FINAL ACTION WRITTEN
Sunday, December 26, 2021ASSIGNED TO EXAMINER
Friday, July 23, 2021APPLICATION FILING RECEIPT MAILED
Monday, July 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 15, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB